Keyword: GlaxoSmithKline (GSK)
News
26.01.2016
- More than 80 international drug and biotechnology companies have urged governments to work with them to combat the emergence of drug-resistant superbugs, according to a report by...
News
13.01.2016
- Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...
News
18.12.2015
- US biopharmaceutical group Amgen is buying back from GlaxoSmithKline (GSK) all of its remaining rights to the bone drugs Prolia (denosumab), Xgeva (denosumab) and Vectibix...
News
06.11.2015
- GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...
News
22.10.2015
- Six international drugmakers, led by GlaxoSmithKline (GSK) and including Johnson & Johnson, Biogen, Eli Lilly, Pfizer and Takeda, have joined forces with the UK Department of...
News
13.10.2015
- Israeli generics giant Teva Pharmaceutical Industries has launched a generic equivalent to Glaxo SmithKline’s Avodart (dutasteride) 0.5 mg capsules on the US market. The active...
Markets & Companies
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
Markets & Companies
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
